News | News By Subject | News by Disease News By Date | Search News

Sinusitis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN)'s Dupilumab Successful In Phase 2 Study     9/30/2014
Johnson & Johnson (JNJ) (JOBS) to Pay $785 Million for Sinus-Surgery Company, Acclarent, Inc.     12/18/2009
Accentia Biopharmaceuticals (ABPI) Release: SinuNase(TM) Fast-Tracked Pivotal Phase 3 Study in Chronic Sinusitis Shows Statistically Significant Objective Evidence of Superiority of SinuNase Over Control Lavage in Severe Cases     4/30/2008
Accentia Biopharmaceuticals (ABPI) Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis     8/15/2007
Accentia, Inc. Says Interim Data on SinuNase Promising     6/28/2007
Oscient Pharmaceuticals Corporation (OSCI) Announces Results Of FDA Advisory Committee Meeting For FACTIVE Tablets For The Treatment Of Acute Bacterial Sinusitis; Drug Rejected By Panel     9/13/2006
Oscient Pharmaceuticals Corporation (OSCI) Stock Trading Halted Today; FDA Advisory Committee To Discuss FACTIVE(R) sNDA For Acute Bacterial Sinusitis     9/12/2006
FDA Grants Accentia Biopharmaceuticals Fast Track Status For SinuNase(TM)     4/12/2006
Ortho-McNeil, Inc. Release: LEVAQUIN(R) FDA Approved For Short-Course Treatment Of Acute Bacterial Sinusitis     8/8/2005
Pfizer Inc.'s (PFE) Single-Dose Antibiotic Zmax(TM) Receives FDA Approval     6/13/2005
Pfizer Inc.'s (PFE) Zithromax Receives FDA Approval As A Once-Daily, Three-Day Treatment For Acute Bacterial Sinusitis     1/20/2004

News from Around the Web
What Causes Sinus Infections? University of California, San Francisco (UCSF) Study     9/13/2012
For Severe Sinusitis, Oral Steroids an Option, University of Dundee Study Says     3/1/2011
Inappropriate Drugs Still Given for Sinus Woes Finds Centers for Disease Control and Prevention (CDC)     12/28/2010
Honey Effective In Killing Bacteria That Cause Chronic Sinusitis, University of Ottawa Study     9/23/2008
'Stuffy Nose' Mouse in Johns Hopkins University Study: A Promise to Help Treat 31 Million With Sinusitis     7/23/2008
Study Questions Drug Treatments for Sinus Ills     12/5/2007
New Vaccine Would Target Ear, Sinus Infections     9/26/2006
Bacteria Get Off Easy In Sinus Infections     9/15/2006
Johns Hopkins University School of Medicine Scientists Link Immune Response To "Ghost"' Parasites And Severely Congested Sinuses     9/7/2006
Study Finds No Drug Resistance In Sinus Treatments     10/19/2004
Researchers Have Found A Starting Point To Establishing The Genetic Basis For Sinus Disease     10/8/2004
Researchers Probe Link Between Acid Reflux And Sinusitis     5/28/2004
Electronic "Nose" Sniffs Out Pneumonia, Sinusitis     4/30/2004
Chronic Sinusitis Is Immune Response To Fungus; New Antifungal Medicine Helps Sufferers     3/24/2004
Sleepless Nights? Could Be Sinus Trouble     1/19/2004

Press Releases
Bay Area's Intersect ENT Gets a PDUFA Date From the FDA for Steroid Releasing Sinus Implant     5/22/2017
Renowned Sinus Surgeon Dr. Peter-John Wormald Comments On AmpliPhi Bio (APHB)’ Favorable Phase I Results Of AB-SA01 In Chronic Rhinosinusitis Patients     1/4/2017
Entellus Medical (ENTL) Release: NIH And NICE Provides Positive Guidance For Use Of The Xpress Multi-Sinus Dilation System For Treating Chronic Sinusitis     12/13/2016
Sanovas Launches Sinus Endoscopy Biz for Office Based Treatments of Chronic Sinusitis     12/1/2016
AmpliPhi Bio (APHB) Announces Favorable Topline Safety And Tolerability Results From Its Phase I Trial In Patients With Chronic Rhinosinusitis     10/25/2016
BioSTAR To Launch A New Product Aimed At Treating Effects Of Rhinitis And Sinusitis     10/11/2016
AmpliPhi Bio (APHB) Provides Update On Phase I Trial In Chronic Rhinosinusitis Patients     9/20/2016
OptiNose AS Release: New Research Highlights The Burden Of Illness Suffered By Chronic Rhinosinusitis Patients     9/19/2016
Intersect ENT Announces American Rhinologic Society Endorsement Of The Use Of Drug Eluting Sinus Implants     9/19/2016
OptiNose AS Presents Data From Phase III Trials With Investigational Product Using Exhalation Delivery System Technology For Treatment In Patients With Chronic Rhinosinusitis (CRS) With And Without Nasal Polyps     9/16/2016
Procter & Gamble (PG) Release: Vicks Expands Sinex Portfolio To Offer Targeted Solutions To Treat Sinus Symptoms     9/7/2016
Intersect ENT Announces Completion Of Enrollment In RESOLVE II Clinical Trial Of New In-Office Implant For Recurrent Chronic Sinusitis     6/1/2016
Intersect ENT Announces Positive Clinical Results From Pivotal Study Of Newest Steroid Releasing Sinus Implant     5/16/2016
Bay Area's Intersect ENT Wins FDA Approval of Additional Indication for PROPEL Mini Sinus Implant     3/24/2016
Intersect ENT Announces NUB Status 1 Designation For PROPEL Sinus Implant In Germany     1/29/2016